PriceTargets.com logo

Bangkok Dusit Medical Services Public - BDULF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.85 As of 12/3/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for BDULF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bangkok Dusit Medical Services Public Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BDULF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BDULF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Bangkok Dusit Medical Services Public in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.85.

This chart shows the closing price for BDULF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Bangkok Dusit Medical Services Public. This rating has held steady since August 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/22/2023MacquarieInitiated CoverageOutperform
4/3/2023The Goldman Sachs GroupUpgradeNeutral ➝ Buy
(Data available from 12/4/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Bangkok Dusit Medical Services Public

Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally. The company operates hospitals under the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group names. It also offers laboratory, clinic, holistic clinical wellness, accounting, technology and information, training, investment and asset management, air transportation, skin and aesthetics telemedicine, and whole genome sequencing services; operates hotels; provides health insurance and insurance brokerage services; and distributes health products, cosmetic products, and facility management. In addition, the company is involved in production and distribution of medicines and pharmaceutical products; real estate; e-commerce; and investment and operation of BDMS silver wellness and residence products. Bangkok Dusit Medical Services Public Company Limited was founded in 1969 and is based in Bangkok, Thailand.
Read More

Today's Range

Now: $0.85
Low: $0.85
High: $0.85

50 Day Range

MA: $0.80
Low: $0.73
High: $0.85

52 Week Range

Now: $0.85
Low: $0.85
High: $0.85

Volume

N/A

Average Volume

7,667 shs

Market Capitalization

N/A

P/E Ratio

1.90

Dividend Yield

1.03%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Bangkok Dusit Medical Services Public?

The following Wall Street research analysts have issued reports on Bangkok Dusit Medical Services Public in the last twelve months:
View the latest analyst ratings for BDULF.

What is the current price target for Bangkok Dusit Medical Services Public?

0 Wall Street analysts have set twelve-month price targets for Bangkok Dusit Medical Services Public in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Bangkok Dusit Medical Services Public in the next year.
View the latest price targets for BDULF.

What is the current consensus analyst rating for Bangkok Dusit Medical Services Public?

Bangkok Dusit Medical Services Public currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BDULF.

What other companies compete with Bangkok Dusit Medical Services Public?

Other companies that are similar to Bangkok Dusit Medical Services Public include American Oncology Network, American Oncology Network, Bumrungrad Hospital Public, CareRx and dentalcorp. Learn More about companies similar to Bangkok Dusit Medical Services Public.

How do I contact Bangkok Dusit Medical Services Public's investor relations team?

Bangkok Dusit Medical Services Public's physical mailing address is 2, Soi Soonvijai 7, New Petchburi Road Bang Kapi Huaykwang, Bangkok 10310, Thailand. The company's listed phone number is 66-2-310-3000. The official website for Bangkok Dusit Medical Services Public is www.bdms.co.th. Learn More about contacing Bangkok Dusit Medical Services Public investor relations.